Health Sciences

UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.

The Latest

Events, Activities Emphasize Importance of Ethics for Scholars and Scientists

As a public research university, UC San Diego is committed to the highest standards of integrity in research.

UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center

Roughly one-quarter of all Americans – an estimated 100 million adults and children – have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and liver failure. Combining a diverse array of basic science, biomarkers, imaging and clinical efforts, University of California, San Diego School of Medicine has launched a new NAFLD Research Center to better understand the disease and develop treatments where none currently exist.

Prominent Circadian Biologists Gather for Influential Annual Symposium

Some of the most prominent scientists conducting very “timely” research are coming to campus.

UC San Diego Researchers Cited Among “World’s Most Influential Scientific Minds”

Twenty-two University of California, San Diego scientists and physicians are among the 2015 listing of “The World’s Most Influential Scientific Minds,” an annual compendium of “Highly Cited Researchers” by Thomson Reuters, a multinational mass media and information company.

UC San Diego Skaggs School of Pharmacy and Janssen R&D Collaborate to Treat Chagas Disease

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego have entered into a research collaboration with Janssen Research & Development, LLC (Janssen R&D), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to identify new therapeutic targets for Chagas disease, a parasitic infection that is the leading cause of heart failure in Latin America.

New Class of Anti-infective Drugs May Overcome Antibiotic Resistance

A team of researchers, with the aid of the Gordon supercomputer at the San Diego Supercomputer Center based at UC San Diego, has identified a class of possible antibiotics with the potential to disable previously drug-resistant bacteria.